IBN SINA Pharmaceutical Industry Future Growth
Future criteria checks 4/6
IBN SINA Pharmaceutical Industry is forecast to grow earnings and revenue by 19.2% and 14.4% per annum respectively. EPS is expected to grow by 19.2% per annum. Return on equity is forecast to be 23% in 3 years.
Key information
19.2%
Earnings growth rate
19.2%
EPS growth rate
Pharmaceuticals earnings growth | 16.7% |
Revenue growth rate | 14.4% |
Future return on equity | 23.0% |
Analyst coverage | Low |
Last updated | 05 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 17,062 | 1,246 | 813 | 1,427 | 1 |
6/30/2026 | 15,033 | 1,042 | 654 | 1,209 | 1 |
6/30/2025 | 12,739 | 813 | 474 | 965 | 1 |
6/30/2024 | 11,224 | 712 | -278 | 657 | 1 |
3/31/2024 | 10,866 | 690 | -341 | 816 | N/A |
12/31/2023 | 10,335 | 648 | -144 | 788 | N/A |
9/30/2023 | 9,566 | 624 | 5 | 704 | N/A |
6/30/2023 | 9,125 | 605 | 192 | 877 | N/A |
3/31/2023 | 8,712 | 614 | 173 | 612 | N/A |
12/31/2022 | 8,568 | 607 | 238 | 549 | N/A |
9/30/2022 | 8,570 | 609 | 65 | 527 | N/A |
6/30/2022 | 8,480 | 606 | 53 | 419 | N/A |
3/31/2022 | 8,384 | 562 | 235 | 462 | N/A |
12/31/2021 | 8,296 | 563 | 214 | 529 | N/A |
9/30/2021 | 8,015 | 529 | 244 | 505 | N/A |
6/30/2021 | 7,376 | 489 | 310 | 552 | N/A |
3/31/2021 | 6,986 | 433 | 254 | 642 | N/A |
12/31/2020 | 6,730 | 419 | 375 | 709 | N/A |
9/30/2020 | 6,384 | 405 | -127 | 484 | N/A |
6/30/2020 | 6,192 | 393 | -115 | 498 | N/A |
3/31/2020 | 6,051 | 389 | -293 | 338 | N/A |
12/31/2019 | 5,761 | 378 | -372 | 255 | N/A |
9/30/2019 | 5,473 | 350 | 159 | 467 | N/A |
6/30/2019 | 5,264 | 336 | 44 | 433 | N/A |
3/31/2019 | 4,978 | 483 | -69 | 431 | N/A |
12/31/2018 | 4,759 | 469 | -204 | 265 | N/A |
9/30/2018 | 4,747 | 467 | -275 | 194 | N/A |
6/30/2018 | 4,657 | 452 | -340 | 192 | N/A |
3/31/2018 | 4,543 | 267 | -269 | 157 | N/A |
12/31/2017 | 4,500 | 258 | N/A | 263 | N/A |
9/30/2017 | 4,312 | 252 | N/A | 229 | N/A |
6/30/2017 | 4,009 | 234 | N/A | 124 | N/A |
3/31/2017 | 3,951 | 224 | N/A | 299 | N/A |
12/31/2016 | 3,781 | 224 | N/A | 303 | N/A |
9/30/2016 | 3,689 | 221 | N/A | 372 | N/A |
6/30/2016 | 3,491 | 203 | N/A | 385 | N/A |
3/31/2016 | 3,294 | 193 | N/A | 224 | N/A |
12/31/2015 | 3,163 | 178 | N/A | 216 | N/A |
9/30/2015 | 2,931 | 147 | N/A | 175 | N/A |
6/30/2015 | 2,922 | 145 | N/A | 142 | N/A |
3/31/2015 | 2,815 | 136 | N/A | 200 | N/A |
12/31/2014 | 2,679 | 127 | N/A | 174 | N/A |
9/30/2014 | 2,609 | 102 | N/A | 92 | N/A |
6/30/2014 | 2,454 | 99 | N/A | 124 | N/A |
3/31/2014 | 2,305 | 90 | N/A | 69 | N/A |
12/31/2013 | 2,209 | 87 | N/A | 51 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IBNSINA's forecast earnings growth (19.2% per year) is above the savings rate (3.7%).
Earnings vs Market: IBNSINA's earnings (19.2% per year) are forecast to grow faster than the BD market (17.1% per year).
High Growth Earnings: IBNSINA's earnings are forecast to grow, but not significantly.
Revenue vs Market: IBNSINA's revenue (14.4% per year) is forecast to grow faster than the BD market (9.1% per year).
High Growth Revenue: IBNSINA's revenue (14.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IBNSINA's Return on Equity is forecast to be high in 3 years time (23%)